Clinical trials located in

Praha

Praha city is located in Czechia. Currently, 2 clinical trials are being conducted in this city.

  • CT-EU-00118816

    Study on the safety and effectiveness of Setanaxib for Alport Syndrome patients

    The purpose of this study is to learn about the safety and tolerability of a drug called setanaxib in patients with Alport syndrome, when added to their standard of care treatment. The study will compare how safe setanaxib is when compared to a placebo. Participants will be asked about any side effects they experience at each study visit. Additionally, tests in blood, urine, and other examinations will be used to assess the safety of setanaxib. The study will also measure how well setanaxib works in comparison to a placebo by measuring urine protein and certain markers in the blood and urine. The concentration of setanaxib in the blood will also be measured throughout the course of the study.

    This is a Phase 2a, randomized, double-blind, placebo-controlled study. This means that participants will be randomly assigned to receive either setanaxib or a placebo, and neither the participants nor the researchers will know who is receiving which treatment.

    • placebo
    • Setanaxib
  • Study of a new drug for moderate to severe Rotator Cuff Tendinopathy

    The clinical trial examines the use of secukinumab, a drug, for treating moderate to severe rotator cuff tendinopathy—a shoulder condition characterized by pain and limited movement. The study explores whether secukinumab can improve symptoms and physical function compared to a placebo. Participants will receive either the drug or placebo in addition to standard care, under a randomized, double-blind, and placebo-controlled setup, to ensure the results are unbiased.

    • placebo
    • Secukinumab

See more clinical trials in other cities in Czechia:

.